Kazakhstan Pharmaceuticals and Healthcare Report Q2 2013Business Monitor International
April 10, 2013
83 Pages - SKU: BMI5017079
More Prescription Drugs reports by Business Monitor International
Nigeria Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
Executive SummaryBMI View: Boosting bilateral co-operation between Nigerian buyers and Indian drugmakers will directlyobstruct the Nigerian government's goal to increase self-sufficiency in medicines production. We ...
Namibia Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees ...
Mexico Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor International
BMI View: The improving performance of Mexico's regulatory system presents more opportunities formultinational pharmaceutical companies seeking to enter the Mexican pharmaceutical market. On the backof ...
Gabon Pharmaceuticals and Healthcare Report Q3 2013 by Business Monitor InternationalSee all reports like this >>
BMI View: Increased longevity in developed markets translates into an increased demand for care for theelderly, healthcare services and medicines. However, despite increased life expectancy, ...
More Kazakhstan Prescription Drugs reports
Antibiotics Market in Kazakhstan to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Kazakhstan. The study provides essential market ...
Kazakhstan Pharmaceuticals and Healthcare Report Q2 2012 by Business Monitor InternationalSee all reports like this >>
BMI View: Kazakhstan remains the most accessible and competitive pharmaceutical market in Central Asia and the growing expectation it will gain World Trade Organisation (WTO) ...
More Kazakhstan reports
D&B Country RiskLine Report: Kazakhstan by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Kazakhstan by Dun & Bradstreet Inc.See all reports like this >>
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Hospitals & Clinics
- Country Overviews
- Life Sciences
- Country Overviews
- Manufacturing, Packaging & Detailing
- Prescription Drugs
Prescription Drugs Reports